Phase 2 Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with schizophrenia (based on standard medical guidelines called DSM-5), and your doctor believes a lower-than-usual starting dose of the medication olanzapine is more appropriate for you based on your overall health
- You have had schizophrenia for more than 1 year at the time of your first study visit
Who may not be able to join:
- You have been diagnosed with a related but different mental health condition, such as schizoaffective disorder, bipolar disorder, or depressive disorder (based on DSM-5 guidelines), at the time of your first study visit
- You have been admitted to a hospital due to worsening schizophrenia within the past 12 weeks before your first study visit
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +82+2-708-8000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The mean change of PANSS(Positive and Negative Syndrome Scale) total score; Incidence of treatment-emergent adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.